BORDEAUX, France. (September, 13, 2021) - TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75 million (EUR64M) Series B…
Read More
© 2024 Leonard Green & Partners, L.P. All rights reserved.